Authors:
MAYSER P
PICKEL M
HAZE P
ERDMANN F
PAPAVASSILIS C
SCHMIDT R
Citation: P. Mayser et al., DIFFERENT UTILIZATION OF NEUTRAL LIPIDS BY MALASSEZIA-FURFUR AND MALASSEZIA-SYMPODIALIS, MEDICAL MYCOLOGY, 36(1), 1998, pp. 7-14
Authors:
MAYSER P
IMKAMPE A
WINKELER M
PAPAVASSILIS C
Citation: P. Mayser et al., GROWTH REQUIREMENTS AND NITROGEN-METABOLISM OF MALASSEZIA-FURFUR, Archives of dermatological research, 290(5), 1998, pp. 277-282
Authors:
MAYSER P
HAZE P
PAPAVASSILIS C
PICKEL M
GRUENDER K
GUEHO E
Citation: P. Mayser et al., DIFFERENTIATION OF MALASSEZIA SPECIES - SELECTIVITY OF CREMOPHOR EL, CASTOR-OIL AND RICINOLEIC ACID FOR M-FURFUR, British journal of dermatology, 137(2), 1997, pp. 208-213
Authors:
MAYSER P
GRIMMINGER F
PAPAVASSILIS C
SCHLOTZER E
SEEGER W
Citation: P. Mayser et al., REPRODUCIBLE EFFECTS OF INTRAVENOUSLY ADMINISTERED FISH-OIL IN ACUTE RELAPSING PSORIASIS, Journal of dermatological treatment, 7(4), 1996, pp. 211-214
Authors:
GRIMMINGER F
HATTAR K
PAPAVASSILIS C
TEMMESFELD B
CSERNOK E
GROSS WL
SEEGER W
SIBELIUS U
Citation: F. Grimminger et al., NEUTROPHIL ACTIVATION BY ANTIPROTEINASE-3 ANTIBODIES IN WEGENERS-GRANULOMATOSIS - ROLE OF EXOGENOUS ARACHIDONIC-ACID AND LEUKOTRIENE B-4 GENERATION, The Journal of experimental medicine, 184(4), 1996, pp. 1567-1572
Authors:
MAYSER P
HUPPERTZ M
PAPAVASSILIS C
GRUNDER K
Citation: P. Mayser et al., YEASTS OF THE GENUS TRICHOSPORON - IDENTI FICATION, EPIDEMIOLOGY AND SIGNIFICANCE IN DERMATOLOGICAL DISEASE, Hautarzt, 47(12), 1996, pp. 913-920
Authors:
HAMMES HP
WEISS A
FUHRER D
KRAMER HJ
PAPAVASSILIS C
GRIMMINGER F
Citation: Hp. Hammes et al., ACCELERATION OF EXPERIMENTAL DIABETIC-RETINOPATHY IN THE RAT BY OMEGA-3-FATTY-ACIDS, Diabetologia, 39(3), 1996, pp. 251-255
Authors:
GRIMMINGER F
GRIMM H
FUHRER D
PAPAVASSILIS C
LINDEMANN G
BLECHER C
MAYER K
TABESCH F
KRAMER HJ
STEVENS J
SEEGER W
Citation: F. Grimminger et al., OMEGA-3 LIPID INFUSION IN A HEART ALLOTRANSPLANT MODEL - SHIFT IN FATTY-ACID AND LIPID MEDIATOR PROFILES AND PROLONGATION OF TRANSPLANT SURVIVAL, Circulation, 93(2), 1996, pp. 365-371
Authors:
GRIMM H
TIBELL A
NORRLIND B
SCHOTT J
BOHLE RM
PAPAVASSILIS C
FUHRER D
MAYER K
GRIMMINGER F
Citation: H. Grimm et al., IMMUNOSUPPRESSIVITY OF PARENTERAL FAT EMU LSIONS UNDER DEFINED IMMUNOSTIMULATION, Infusionstherapie und Transfusionsmedizin, 22(2), 1995, pp. 110-116
Authors:
GRIMMINGER F
GRIMM H
FUHRER D
PAPAVASSILIS C
MAYER K
KISS I
KRAMER HJ
TEMMESFELD B
SIBELIUS U
SEEGER W
Citation: F. Grimminger et al., INTRAVENOUS N-3 LIPIDS - INFLUENCE ON MEDIATOR METABOLISM AND SURVIVAL OF HEART-TRANSPLANTS IN RATS, The FASEB journal, 8(5), 1994, pp. 10000646-10000646
Authors:
GRIMMINGER F
MAYSER P
PAPAVASSILIS C
THOMAS M
SCHLOTZER E
HEUER KU
FUHRER D
HINSCH KD
WALMRATH D
SCHILL WB
SEEGER W
Citation: F. Grimminger et al., A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF N-3 FATTY-ACID BASED LIPID INFUSION IN ACUTE, EXTENDED GUTTATE PSORIASIS - RAPID IMPROVEMENT OF CLINICAL MANIFESTATIONS AND CHANGES IN NEUTROPHIL LEUKOTRIENE PROFILE, The Clinical investigator, 71(8), 1993, pp. 634-643
Authors:
GRIMMINGER F
FUHRER D
PAPAVASSILIS C
SCHLOTZER E
MAYER K
HEUER KU
KISS L
WALMRATH D
PIBERHOFER S
LUBBECKE F
KRAMER HJ
STEVENS J
SCHUTTERLE G
SEEGER W
Citation: F. Grimminger et al., INFLUENCE OF INTRAVENOUS N-3 LIPID SUPPLEMENTATION ON FATTY-ACID PROFILES AND LIPID MEDIATOR GENERATION IN A PATIENT WITH SEVERE ULCERATIVE-COLITIS, European journal of clinical investigation, 23(11), 1993, pp. 706-715